Systemic sclerosis (scleroderma) presenting with concurrent inflammatory or fibrotic muscle disease (myopathy) as a documented manifestation.
Verified May 8, 2026 · 4 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 6
- Region
- General
Documentation tips
What should appear in the chart to support M34.82.
Source · Editorial brief grounded in 4 cited references ↓
- Provider must explicitly link the myopathy to systemic sclerosis — document 'myopathy due to systemic sclerosis' or equivalent language; a generic 'muscle weakness' note is insufficient to support M34.82.
- Record objective findings that support the myopathy component: proximal muscle weakness on exam, elevated CK/aldolase, abnormal EMG, or muscle MRI changes attributed to the scleroderma process.
- If lung involvement is also present, document it separately so both M34.81 and M34.82 can be assigned — multi-organ manifestations each require their own specific subcode.
- Distinguish between inflammatory myopathy (overlap with polymyositis/dermatomyositis) and fibrotic myopathy intrinsic to systemic sclerosis, as this affects downstream management documentation.
- Note any drug therapy (e.g., immunosuppressants) being used to treat the myopathy component — this supports medical necessity and differentiates from drug-induced systemic sclerosis (M34.2).
Related CPT procedures
Procedure codes commonly billed with M34.82. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M34.82 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Defaulting to M34.9 (Systemic sclerosis, unspecified) when the chart clearly documents myopathy — that undercodes and costs the practice a more specific, defensible claim.
- Using M34.82 alongside L94.0 (circumscribed scleroderma) or P83.88 (neonatal scleroderma) — both are Excludes1 at the M34 category level and cannot be coded simultaneously.
- Assigning a separate myopathy code (e.g., G72.89) for the muscle disease when it is documented as a manifestation of the systemic sclerosis — M34.82 already captures both conditions as a combination code.
- Failing to assign M34.81 in addition to M34.82 when both lung involvement and myopathy are documented — each manifestation subcode can and should be reported when clinically present.
Clinical context
Source · Editorial summary grounded in 4 cited references ↓
M34.82 codes systemic sclerosis when the treating provider explicitly documents myopathy as a manifestation of the underlying connective tissue disease. This includes scleroderma-associated inflammatory myopathy, fibrotic myopathy, or overlap presentations where muscle weakness, elevated muscle enzymes, or abnormal EMG/MRI findings are attributed to the systemic sclerosis process itself. Use this code only when the myopathy is documented as part of the systemic sclerosis — not as a separate, independently coded condition.
M34.82 sits under parent code M34.8 (Other forms of systemic sclerosis), which groups the organ-specific manifestation codes. Its siblings are M34.81 (with lung involvement) and M34.83 (with polyneuropathy). When multiple organ manifestations coexist — for example, lung involvement and myopathy in the same patient — assign both M34.81 and M34.82. M34.89 (Other systemic sclerosis) is the catch-all for documented systemic sclerosis manifestations that don't fit the named subcodes.
The category-level Excludes1 at M34 prohibits simultaneous use with circumscribed scleroderma (L94.0) or neonatal scleroderma (P83.88) — those conditions cannot occur together with systemic sclerosis under ICD-10-CM logic. MS-DRG v43.0 groups M34.82 into DRGs 545–547 (Connective tissue disorders with/without MCC/CC), so accurate comorbidity capture directly affects reimbursement tier.
Sibling codes
Other billable codes under M34.8 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 4 cited references ↓
01Can I use M34.82 and a separate myopathy code together?
02What if the patient has both lung involvement and myopathy from systemic sclerosis?
03Is M34.82 appropriate for overlap syndrome with polymyositis or dermatomyositis?
04What is the difference between M34.82 and M34.83?
05Does M34.82 require a 7th-character extension?
06Which MS-DRGs does M34.82 map to?
07Can M34.82 be used if systemic sclerosis was induced by a drug?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M30-M36/M34-/M34.82
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M34.82
- 04outsourcestrategies.comhttps://www.outsourcestrategies.com/blog/reporting-systemic-sclerosis-connective-tissue-disorder/
Mira AI Scribe
Mira's AI scribe captures the provider's explicit attribution of myopathy to systemic sclerosis — documenting proximal muscle weakness, enzyme elevation (CK, aldolase), EMG findings, or muscle imaging results alongside the scleroderma diagnosis. That linkage prevents a drop to M34.9 (unspecified) and supports the higher-specificity code that payers require for connective tissue disorder DRG assignment.
See how Mira captures M34.82 documentation